Announcement Under Regulation 30 Of SEBI LODR
We are pleased to inform that Amrutanjan Health Care Limited has recently been presented with the Award for Brand Excellence in Health Care Sector in the Tamilnadu Best Brand Leadership Awards, 2018. Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In compliance with Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), enclosed herewith copy of the notice to members dated November 1, 2018 seeking approval of the matters as set out therein by way of Postal Ballot/ electronic voting (e-voting)along with the Postal Ballot Form and Calendar of events. The Company has engaged the services of Central Depository Services (India) Limited (CDSL) for providing... Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company at its meeting held today (November 1, 2018) have inter alia, approved the re-appointment of Mr. S Sambhu Prasad (DIN :00015729) as Chairman & Managing Director for a further period of five years from 1st April, 2019 to 31st March, 2024 which is subject to approval of shareholders. The Board has decided to seek the approval of shareholders through Postal Ballot Process for the above re-appointment. Disclosure... Fixes Record Date As November 13,2018
In terms of regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at their meeting held today (November 1, 2018) has fixed Tuesday, November 13, 2018 as Record- date / Cut-off date for determining the eligibility of shareholders', with regard to : a.Payment of First Interim dividend declared for the financial year 2018-19 and b.Receipt of Postal Ballot Notice Corporate Action-Board approves Dividend
The Board of Directors of the Company at its meeting held today (November 1, 2018) had inter-alia Declared First Interim Dividend of Re. 0.55 per share for the financial year 2018-2019 on the Equity Shares of the Company Financial Results For The Quarter Ended September 30, 2018
The Board of Directors of the Company at its meeting held today (November 1, 2018) had inter-alia Approved the Un-audited Financial Results for the quarter ended September 30, 2018. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. Outcome of Board Meeting
In terms of Regulation 30, 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (November 1, 2018) had inter-alia : (i)Approved the Un-audited Financial Results for the quarter ended September 30, 2018. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed.... Fixes Tuesday, November 13, 2018 As Record Date
Pursuant to regulation 42 of SEBI LODR, we wish to inform that the Company has fixed Tuesday, November 13, 2018 as record date for payment of dividend, if approved, to members whose name appears in the Register of Members and the Beneficial Owners as per the details received from National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) as on the record date. Announcement under Regulation 30 (LODR)-Newspaper Publication
Amrutanjan Health Care Limited informs the Exchange regarding ''Newspaper Advertisement published in 'Financial Express' and 'Malai Sudar', both dated October 25, 2018 intimating Board Meeting to be held on November 1, 2018 ''to consider, approve and take on record the Un-audited Financial Results for the Quarter ended September 30, 2018 Closure of Trading Window
Amrutanjan has informed BSE that Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per Company's Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Promoters, Directors, Designated Employees, etc) from October 25, 2018 to November 4, 2018 (both days inclusive) for the purpose of meeting of the Board...